Opal Biosciences Investor Briefing, Sydney 13 July 2015
Opal Biosciences Investor Briefing, Melbourne 14 July 2015
December 2014
January 2013
July 2012
2018 BioDiem Annual Report Notice of Annual General Meeting and Explanatory Statement and Proxy Form
Infectious disease therapy and vaccine development company BioDiem Ltd and its subsidiary company Opal Biosciences Ltd (“Opal”) are pleased to provide the following information.
